E. Brendan Magrab
Chief Executive Officer presso Transpharmative Advisors LLC
Profilo
E.
Brendan Magrab is currently the President & Chief Executive Officer at Transpharmative Advisors LLC since 2013 and also the President, Chief Executive Officer & Director at Epalex Corp.
since 2019.
He was previously the Director at Inhibitor Therapeutics, Inc. from 2016 to 2019, Vice President-Intellectual Property at Zoetis Products LLC from 2000 to 2004, and EVP-Commercial Operations & General Counsel at URL Pharma, Inc. from 2004 to 2013.
He also worked as a Patent Examiner at the US Patent & Trademark Office and as a Law Clerk at the United States Court of Appeals for the Federal Circuit.
Mr. Magrab received his undergraduate degree from the University of Virginia and his graduate degree from Georgetown University Law Center.
Posizioni attive di E. Brendan Magrab
| Società | Posizione | Inizio |
|---|---|---|
| Transpharmative Advisors LLC | Chief Executive Officer | 01/01/2013 |
Epalex Corp.
 Epalex Corp. Miscellaneous Commercial ServicesCommercial Services Epalex Corp. engages in the development of novel treatments for migraine and epilepsy. The treatment for the first time provides a way for patients with epilepsy to gain control over their seizures. The firm also develops transformational products for seizure prophylaxis in patients suffering from primary generalized epilepsies. The company was founded Randall B. Murphy and is headquartered in Palo Alto, CA. | Chief Executive Officer | 01/01/2019 |
Precedenti posizioni note di E. Brendan Magrab
| Società | Posizione | Fine |
|---|---|---|
| INHIBITOR THERAPEUTICS, INC. | Chairman | 15/04/2019 |
URL Pharma, Inc.
 URL Pharma, Inc. Pharmaceuticals: MajorHealth Technology URL Pharma, Inc. is a pharmaceutical company. Its capabilities include technology development, product development, manufacturing, and commercialization. The company was founded in 1946 and is headquartered in Philadelphia, PA. | General Counsel | 01/02/2013 |
Zoetis Products LLC
 Zoetis Products LLC Pharmaceuticals: MajorHealth Technology Zoetis Products LLC engaged in the manufacturing of pharmaceutical products. The company was founded in 1975 and was headquartered in Florham Park, NJ. | Corporate Officer/Principal | 01/09/2004 |
| United States Court of Appeals for the Federal Circuit | General Counsel | - |
US Patent & Trademark Office
 US Patent & Trademark Office General GovernmentGovernment US Patent & Trademark Office provides patent and trade marks services. It advises the president of the United States, the secretary of commerce, and U.S. government agencies on intellectual property (IP) policy, protection, and enforcement; and promotes IP protection. The company is headquartered in Alexandria, VA. | Corporate Officer/Principal | - |
Formazione di E. Brendan Magrab
| University of Virginia | Undergraduate Degree |
| Georgetown University Law Center | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| INHIBITOR THERAPEUTICS, INC. | Health Technology |
| Aziende private | 6 |
|---|---|
Zoetis Products LLC
Zoetis Products LLC Pharmaceuticals: MajorHealth Technology Zoetis Products LLC engaged in the manufacturing of pharmaceutical products. The company was founded in 1975 and was headquartered in Florham Park, NJ. | Health Technology |
US Patent & Trademark Office
US Patent & Trademark Office General GovernmentGovernment US Patent & Trademark Office provides patent and trade marks services. It advises the president of the United States, the secretary of commerce, and U.S. government agencies on intellectual property (IP) policy, protection, and enforcement; and promotes IP protection. The company is headquartered in Alexandria, VA. | Government |
URL Pharma, Inc.
URL Pharma, Inc. Pharmaceuticals: MajorHealth Technology URL Pharma, Inc. is a pharmaceutical company. Its capabilities include technology development, product development, manufacturing, and commercialization. The company was founded in 1946 and is headquartered in Philadelphia, PA. | Health Technology |
| United States Court of Appeals for the Federal Circuit | Government |
| Transpharmative Advisors LLC | |
Epalex Corp.
Epalex Corp. Miscellaneous Commercial ServicesCommercial Services Epalex Corp. engages in the development of novel treatments for migraine and epilepsy. The treatment for the first time provides a way for patients with epilepsy to gain control over their seizures. The firm also develops transformational products for seizure prophylaxis in patients suffering from primary generalized epilepsies. The company was founded Randall B. Murphy and is headquartered in Palo Alto, CA. | Commercial Services |
- Borsa valori
- Insiders
- E. Brendan Magrab
